Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) has been postulated to participate in a number of diverse physiological and pathological processes ranging from the homeostasis of plasma lipoproteins, atherosclerosis, and fibrinolysis to neuronal regeneration and survival. It has not been possible to demonstrate in vivo the physiological significance of LRP for each of these complex processes by a conventional gene knockout approach because LRP is essential for embryonic development. Here we have used the Cre/loxP recombination system to achieve inducible, tissue-specific and quantitative disruption of the LRP gene in adult mice. Inactivation of LRP in the livers of LDL receptor-deficient mice resulted in the accumulation of cholesterol-rich remnant lipoproteins in the circulation. In normal animals, this caused a compensatory upregulation of the LDL receptor in the liver. Conditional gene targeting has thus allowed us to isolate a specific physiological function of LRP for in vivo analysis and has provided unequivocal evidence for another LDL receptor-independent cholesterol clearance pathway in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Self-citationHerz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 959
Self-citation
Cited by
Items 101–200 of 453
Apolipoprotein A-V Interaction with Members of the Low Density Lipoprotein Receptor Gene Family
Nilsson, S. K., Lookene, A., Beckstead, J. A., Gliemann, J., Ryan, R. O., & Olivecrona, G. (2007) · Biochemistry · doi:10.1021/bi7000533 · Cited by 102
Laatsch, A., Merkel, M., Talmud, P. J., Grewal, T., Beisiegel†, U., & Heeren, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.046 · Cited by 111
“[6] Rohlmann A, Gotthardt M, Hammer RE, Herz J.”
BackgroundInfluentialLinton, M. F., Hasty, A. H., Babaev, V. R., & Fazio, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2181 · Cited by 100
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Reyes-Soffer, G., Sztalryd, C., Horenstein, R. B., Holleran, S., Matveyenko, A., Thomas, T., Nandakumar, R., Ngai, C., Karmally, W., Ginsberg, H. N., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311476 · Cited by 97
“A simple explanation for our results might be that more efficient LpL-mediated lipolysis of nascent VLDL resulted in smaller VLDL that were more depleted of TG than post-lipolysis VLDL in nonaffected individuals and, therefore, more likely to be converted to IDL and LDL by additional lipolytic activities during the se…”
ResultRole for LAMP-2 in endosomal cholesterol transport
Schneede, A., Schmidt, C. K., Hölttä-Vuori, M., Heeren, J., Willenborg, M., Blanz, J., Domanskyy, M., Breiden, B., Brodesser, S., Landgrebe, J., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00973.x · Cited by 96
“In agreement with previous reports on elevated LDLR levels in LDL receptor related protein 1 (LRP1) deficient hepatocytes [32], we observed a concomitant reduction of LRP1 expression in LAMP / MEFs (Fig.”
ResultUptake of postprandial lipoproteins into bone in vivo: Impact on osteoblast function
Niemeier, A., Niedzielska, D., Seçer, R., Schilling, A. F., Merkel, M., Enrich, C., Rensen, P. C. N., & Heeren, J. (2008) · Bone · doi:10.1016/j.bone.2008.03.022 · Cited by 100
“The majority of CR is cleared by the liver via receptor-mediated endocytosis through the low density lipoprotein (LDL) receptor and LDL receptor related protein 1 (LRP1) [14,15].”
BackgroundAntiretroviral therapy-associated hyperlipidaemia in HIV disease
Mooser, V., & Carr, A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00011 · Cited by 101
Heeren, J., Grewal, T., Laatsch, A., Rottke, D., Rinninger, F., Enrich, C., & Beisiegel, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209006200 · Cited by 73
Zanoni, P., Velagapudi, S., Yalcinkaya, M., Rohrer, L., & von Eckardstein, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.881 · Cited by 95
Malaria circumsporozoite protein inhibits the respiratory burst in Kupffer cells
Usynin, I., Klotz, C., & Frevert, U. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00982.x · Cited by 94
“To define the role of LRP-1 in sporozoite infection of the liver, transgenic LRP-1flox/flox Cre+ mice with a functional defect of LRP-1 in hepatocytes were generated by conditional gene targeting (Rohlmann et al., 1996; 1998).”
MethodRaffai, R. L., Loeb, S. M., & Weisgraber, K. H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000152613.83243.12 · Cited by 94
Lipolysis Stimulated Lipoprotein Receptor
Yen, F. T., Roitel, O., Bonnard, L., Notet, V., Pratte, D., Stenger, C., Magueur, E., & Bihain, B. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801027200 · Cited by 93
Liu, Q., Zhang, J., Zerbinatti, C., Zhan, Y., Kolber, B. J., Herz, J., Muglia, L. J., & Bu, G. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000575 · Cited by 92
“Neuronal Deletion of Lrp1 in the Adult Mouse Brain Leads to Obesity To investigate the roles of LRP1 in the adult CNS, we generated conditional Lrp1 forebrain knockout mice (LRP1-KO) by crossing Lrp1 floxP mice [2] with aCamKII-Cre mice [8].”
BackgroundMethodSelf-citationAncsin, J. B., & Kisilevsky, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401979200 · Cited by 97
Jones, C., Hammer, R. E., Li, W.-P., Cohen, J. C., Hobbs, H. H., & Herz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304855200 · Cited by 80
Self-citationRecent insights into factors affecting remnant lipoprotein uptake
Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91
Li, Y., Gerbod-Giannone, M.-C., Seitz, H., Cui, D., Thorp, E., Tall, A. R., Matsushima, G. K., & Tabas, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510579200 · Cited by 91
Molecular mechanisms of apolipoprotein B mRNA editing
Anant, S., & Davidson, N. O. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00009 · Cited by 111
Characterization of the Soluble Form of the Low Density Lipoprotein Receptor-Related Protein (LRP)
Quinn, K. A., Pye, V. J., Dai, Y.-P., Chesterman, C. N., & Owensby, D. A. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4590 · Cited by 90
Hiesberger, T., Hüttler, S., Rohlmann, A., Schneider, W., Sandhoff, K., & Herz, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4617 · Cited by 74
“Functions for LRP in the cellular uptake of proteases, protease inhibitor complexes, lipoproteins and lipases are well established (Krieger and Herz, 1994; Rohlmann et al., 1998).”
BackgroundResultSelf-citationLiu, J., Zhang, H., Li, Z., Hailemariam, T. K., Chakraborty, M., Jiang, K., Qiu, D., Bui, H. H., Peake, D. A., Kuo, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185223 · Cited by 96
Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein
GORETZKI, L., & MUELLER, B. M. (1998) · Biochemical Journal · doi:10.1042/bj3360381 · Cited by 74
Hyperlipoproteinemia Type 3: The Forgotten Phenotype
Hopkins, P. N., Brinton, E. A., & Nanjee, M. N. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0440-2 · Cited by 93
Lipometabolism and Glycometabolism in Liver Diseases
Ding, H., Wang, J., Ren, H., & Shi, X. (2018) · BioMed Research International · doi:10.1155/2018/1287127 · Cited by 96
“Triglycerides are delivered to the liver for lipid metabolism and absorbed by liver cells, which is regulated by LDL (low density lipoprotein) receptors and LRP (LDL receptor-related proteins) [1, 2].”
BackgroundAsialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit
Tozawa, R.-I., Ishibashi, S., Osuga, J.-I., Yamamoto, K., Yagyu, H., Ohashi, K., Tamura, Y., Yahagi, N., Iizuka, Y., Okazaki, H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011063200 · Cited by 78
Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I. J., & Shachter, N. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8283 · Cited by 86
“In otherwise normal mice, decreased LRP activity produces LDL-R upregulation and increased plasma apoB48 but no significant alterations in plasma TG and cholesterol have been reported (72).”
BackgroundDing, Y., Xian, X., Holland, W. L., Tsai, S., & Herz, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.002 · Cited by 85
“01), as would be expected (Rohlmann et al., 1998), but this difference was abolished in mice on a HFD.”
BackgroundMethodInfluentialSelf-citationMyeloid Cell Receptor LRP1/CD91 Regulates Monocyte Recruitment and Angiogenesis in Tumors
Staudt, N. D., Jo, M., Hu, J., Bristow, J. M., Pizzo, D. P., Gaultier, A., VandenBerg, S. R., & Gonias, S. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4233 · Cited by 97
“Mice in which the promoter and first 2 exons of the LRP1 gene areflanked by loxP sites were generated by Rohlmann and colleagues (29).”
MethodYancey, P. G., Ding, Y., Fan, D., Blakemore, J. L., Zhang, Y., Ding, L., Zhang, J., Linton, M. F., & Fazio, S. (2011) · Circulation · doi:10.1161/circulationaha.111.032268 · Cited by 83
Zhang, C., An, J., Strickland, D. K., & Yepes, M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080661 · Cited by 98
Niemeier, A., Kassem, M. S., Toedter, K., Wendt, D., Ruether, W., Beisiegel†, U., & Heeren, J. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041102 · Cited by 90
“Whereas RAP represents a universal inhibitor of ligand binding to the LDLR gene family, lactoferrin and suramin are considered to be specific for LRP1.”
BackgroundInfluentialMolecular Cloning of a Lipolysis-stimulated Remnant Receptor Expressed in the Liver
Yen, F. T., Masson, M., Clossais‐Besnard, N., André, P., Grosset, J., Bougueleret, L., Dumas, J.-B., Guerassimenko, O., & Bihain, B. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13390 · Cited by 94
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
Gonzales, J. C., Gordts, P. L. S. M., Foley, E. M., & Esko, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67398 · Cited by 79
“LRP1 shows overlapping specificity with LDLR, preferentially interacting with ApoE-bearing lipoproteins.”
InfluentialMikhailenko, I., Battey, F. D., Migliorini, M., Ruiz, J. F., Argraves, K., Moayeri, M., & Strickland, D. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104382200 · Cited by 70
The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism?
Babin, P., & Gibbons, G. (2009) · Progress in lipid research · doi:10.1016/j.plipres.2008.11.002 · Cited by 86
“These particles are rapidly removed by the liver via a non-saturable pathway involving a non-specific ‘‘scavenger” pathway mediated by LDL receptor-related protein (LRP) 1 [12,13].”
BackgroundEssential Roles of Lipoxygenases in LDL Oxidation and Development of Atherosclerosis
Takahashi, Y., Zhu, H., & Yoshimoto, T. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.425 · Cited by 87
“These findings suggest the contribution of 12/15-lipoxygenase to atherogenesis not only by initiating LDL oxidation, but also by modulating inflammatory or immunological processes.”
Foley, E. M., Gordts, P. L. S. M., Stanford, K. I., Gonzales, J. C., Lawrence, R., Stoddard, N., & Esko, J. D. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301637 · Cited by 77
“These findings suggest that LRP1 does not play a major role in TRL clearance when LDLR is present, consistent with previous studies.(9,18)”
BackgroundResultInfluentialChen, H., Ji, H., Zhang, M., Liu, Z., Lao, L., Deng, C., Chen, J., & Zhong, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3046-16.2017 · Cited by 79
“…mediating gene inactivation in the liver and immune system where recombination efficiency is high and the extent of Mx1-Cre-induced targeted gene deletion is less in CNS (Kühn et al., 1995; Lam et al., 1997; Lam and Rajewsky 1998; Rohlmann et al., 1998; Radtke et al., 1999; Alonzi et al., 2001).”
BackgroundMethodInfluentialCellular uptake of steroid carrier proteins—Mechanisms and implications
Willnow, T. E., & Nykjær, A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.021 · Cited by 85
“5 (Rohlmann et al., 1998).”
Heeren, J., Niemeier, A., Merkel, M., & Beisiegel†, U. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0351-5 · Cited by 82
Mesli, S., Javorschi, S., Bérard, A. M., Landry, M., Priddle, H., Kivlichan, D., Smith, A. J. H., Yen, F. T., Bihain, B. E., & Darmon, M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04223.x · Cited by 74
“[16] demonstrated that the absence of LRP expression in the livers of LDLR-deficient mice resulted in a large elevation in the plasma concentration of cholesterol and TG that were carried in apo B48containing lipoproteins resembling remnants.”
BackgroundDown-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure
Kim, C., & Vaziri, N. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00166.x · Cited by 74
“CM remnants are removed from the circulation by the liver via hepatic LDL receptor-related protein (LRP) [9, 10].”
BackgroundRecycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo
Heeren, J., Grewal, T., Jäckle, S., & Beisiegel, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107461200 · Cited by 55
Molecular Basis for Vitamin A Uptake and Storage in Vertebrates
Chelstowska, S., Widjaja-Adhi, M., Silvaroli, J., & Golczak, M. (2016) · Nutrients · doi:10.3390/nu8110676 · Cited by 72
“Incorporation of chylomicron remnants by hepatocytes is a receptor-mediated process involving the low density lipoprotein receptor [47].”
BackgroundCellular signalling by lipoprotein receptors
Herz, J., Gotthardt, M., & Willnow, T. E. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00009 · Cited by 58
Self-citationCostales, P., Fuentes‐Prior, P., Castellano, J., Revuelta‐López, E., Corral-Rodríguez, M. Á., Nasarre, L., Badimón, L., & Llorente‐Cortés, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638361 · Cited by 75
“LRP1 is a multifunctional receptor involved in several biological processes and signaling pathways (11, 12), including lipoprotein metabolism (13), cell proliferation and migration (14 – 17), neurotransmission (18), and amyloid- peptide clearance (19).”
BackgroundBres, E. E., & Faissner, A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00031 · Cited by 70
Roebroek, A. J. M., Reekmans, S., Lauwers, A., Feyaerts, N., Smeijers, L., & Hartmann, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.605-616.2006 · Cited by 62
“For Lrp1 these approaches resulted in generation of an early embryonic lethal full knockout phenotype (8, 9) and successful tissue-specific inactivation in liver, brain, and vascular smooth muscle cells using the LoxP/Cre system (3, 20, 24, 25).”
MethodWilsie, L. C., & Orlando, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208786200 · Cited by 68
Pathophysiology of hypertriglyceridemia
Hassing, H. C., Surendran, R. P., Mooij, H. L., Stroes, E. S. G., Nieuwdorp, M., & Dallinga‐Thie, G. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.11.010 · Cited by 85
“ApoE contains positively charged residues, which facilitate binding to negative charged domains on the hepatic receptors, whereas hepatic lipase (HL) and LPL mediates particle-receptor interaction with the LRP1 and HSPG receptors [3,33].”
BackgroundInfluentialOn the Physiological Importance of Endoproteolysis of CAAX Proteins
Bergo, M. O., Lieu, H. D., Gavino, B. J., Ambroziak, P., Otto, J. C., Casey, P. J., Walker, Q. M., & Young, S. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310081200 · Cited by 66
Hypomorphic Apolipoprotein E Mice
Raffaı̈, R. L., & Weisgraber, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111222200 · Cited by 67
The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
Chen, J., Su, Y., Pi, S., Hu, B., & Mao, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.682389 · Cited by 75
“as tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), from the circulation in the liver (30, 31).”
BackgroundLaatsch, A., Panteli, M., Sornsakrin, M., Hoffzimmer, B., Grewal, T., & Heeren, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029385 · Cited by 65
“The role of lipoprotein receptors in TRL uptake and endosomal trafficking of TRL-derived apoE has been investigated in several studies [6,7,11,12,14,16,23].”
BackgroundMethodLeukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling
Tourki, B., & Halade, G. V. (2017) · The FASEB Journal · doi:10.1096/fj.201700109r · Cited by 70
May, P., Bock, H. H., & Nofer, J. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1699-2 · Cited by 75
“…Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy with a conditional inactivation of the LRP-1 gene in the myeloid lineage (LysCre-LRPlox/lox); these mice were generated as described previously (Rohlmann et al. 1998; Zurhove et al. 2008).”
MethodHu, L., Boesten, L. S. M., May, P., Herz, J., Bovenschen, N., Huisman, M. V., Berbée, J. F. P., Havekes, L. M., van Vlijmen, B. J. M., & Tamsma, J. T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000249641.96896.e6 · Cited by 64
Self-citationMakarova, A., Mikhailenko, I., Bugge, T. H., List, K., Lawrence, D. A., & Strickland, D. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309150200 · Cited by 64
Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ
Mao, H., Lockyer, P., Li, L., Ballantyne, C. M., Patterson, C., Xie, L., & Pi, X. (2017) · Nature Communications · doi:10.1038/ncomms14960 · Cited by 63
LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages
Lillis, A. P., Muratoglu, S. C., Au, D. T., Migliorini, M. M., Lee, M., Fried, S. K., MIKHAILENKO, I. A., & Strickland, D. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128903 · Cited by 81
“Förster, Munich) with LDLR, LRP1 mice [24] (kindly provided by J.”
InfluentialZhu, H., Takahashi, Y., Xu, W., Kawajiri, H., Murakami, T., Yamamoto, M., Iseki, S., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212104200 · Cited by 65
Kawano, K., Qin, S.-C., Lin, M., Tall, A. R., & Jiang, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003523200 · Cited by 68
Dyslipidemia in the era of HIV protease inhibitors
Stein, J. H. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.3 · Cited by 66
Wilsie, L. C., Gonzales, A. M., & Orlando, R. A. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-23 · Cited by 60
Phosphorylation of LRP1 Regulation of Transport and Signal Transduction
van der Geer, P. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00154-8 · Cited by 68
Ehrhardt, N., Doche, M. E., Chen, S., Mao, H. Z., Walsh, M. T., Bedoya, C., Guindi, M., Xiong, W., Ignatius Irudayam, J., Iqbal, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx159 · Cited by 60
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia
Jones, C., Garuti, R., Michaely, P., Li, W.-P., Maeda, N., Cohen, J. C., Herz, J., & Hobbs, H. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29415 · Cited by 52
“Mice lacking ARH were crossed with mice containing loxP sites at the LRP locus (26, 27) to generate Arh–/–Lrplox/lox animals.”
MethodSelf-citationLlorente-Cortés, V., Otero-Viñas, M., Camino-López, S., Costales, P., & Badimon, L. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000193618.32611.8b · Cited by 59
Triglyceride-Rich Lipoproteins and Plasma Lipid Transport
Havel, R. J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178756 · Cited by 57
LRP and PDGF Signaling: A Pathway to Atherosclerosis
Boucher, P., & Gotthardt, M. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.12.001 · Cited by 59
Li, Z., Ding, T., Pan, X., Li, Y., Li, R., Sanders, P. E., Kuo, M.-S., Hussain, M. M., Cao, G., & Jiang, X.-C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334664 · Cited by 56
“Plasma Apolipoprotein Measurements—Plasma apolipoprotein levels were determined as previously described (30).”
MethodHistory of Discovery: Platelet-Derived Growth Factor
Bowen‐Pope, D. F., & Raines, E. W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179556 · Cited by 69
Bartelt, A., Behler-Janbeck, F., Beil, F. T., Koehne, T., Müller, B., Schmidt, T., Heine, M., Ochs, L., Yılmaz, T., Dietrich, M. F., et al. (2018) · Bone Research · doi:10.1038/s41413-017-0006-3 · Cited by 60
Self-citationJONG, M. C., van Dijk, K. W., Dahlmans, V. E. H., van der Boom, H., KOBAYASHI, K., Kazuhito, O. K. A., Siest, G., Chan, L., Hofker, M. H., & Havekes, L. M. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380281 · Cited by 56
Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS)
Navazesh, M., Mulligan, R., Karim, R., Mack, W., Ram, S., Seirawan, H., Greenspan, J., Greenspan, D., Phelan, J., Alves, M., et al. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01456.x · Cited by 55
“Studies in mice have failed to produce hyperlipidemia following inhibition of LRP by protease inhibitors (Rohlmann et al., 1998).”
BackgroundKoska, J., Yassine, H., Trenchevska, O., Sinari, S., Schwenke, D. C., Yen, F. T., Billheimer, D., Nelson, R. W., Nedelkov, D., & Reaven, P. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p064816 · Cited by 55
“These additional pathways include the LDL-receptor (44), LDL receptor-related protein 1 (45) and heparan sulfate proteoglycans (46, 47).”
Brifault, C., Gilder, A. S., Laudati, E., Banki, M., & Gonias, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798413 · Cited by 55
Narvekar, P., Díaz, M. B., Krones, A., Hardeland, U., Strzoda, D., Stöhr, S., Frohme, M., & Herzig, S. (2009) · Diabetes · doi:10.2337/db08-1184 · Cited by 69
“Thus far, the LDL receptor (LDLR), the LDL receptor-related protein (LRP) 1, and scavenger receptor (SR)-B1 have been found to play only secondary roles in remnant clearance (7-11).”
Receptor and non-receptor mediated uptake of chylomicron remnants by the liver
Havel, R. J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00211-1 · Cited by 70
“Herz and associates found that the hepatic LDL receptor is up-regulated in the liver of the LRP knockout mouse [47], leading them to suggest that LRP may participate in the endocytosis of CR in wild-type mice.”
BackgroundInfluentialOhlsson, C., Sjögren, K., Jansson, J., & Isaksson, O. G. P. (2000) · Pediatric Nephrology · doi:10.1007/s004670000348 · Cited by 63
“Interferon (IFN) induction of mice with the Cre-recombinase under the control of an IFN-responsive promoter (Mx-Cre) has previously been shown to cause almost 100% recombination in the liver, while the recombination in peripheral tissues such as muscle, fat, kidney, heart, and bone is low [20, 22 ].”
BackgroundRecycling of Apolipoprotein E in Mouse Liver
Fazio, S., Linton, M. F., Hasty, A. H., & Swift, L. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8247 · Cited by 53
Romagnuolo, R., Scipione, C. A., Marcovina, S. M., Gemin, M., Seidah, N. G., Boffa, M. B., & Koschinsky, M. L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180869 · Cited by 52
Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism
Bishop, J. R., Stanford, K. I., & Esko, J. D. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282feec2d · Cited by 49
Recent advances in inducible expression in transgenic mice
Albanese, C., Hulit, J., Sakamaki, T., & Pestell, R. G. (2002) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084-9521(02)00021-6 · Cited by 58
Linton, M. F., & Fazio, S. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00003 · Cited by 51
Battlay, P., Schmidt, J. M., Fournier‐Level, A., & Robin, C. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.031054 · Cited by 50
“Its role in hepatocytes has been characterized in its mouse homologue, where it functions as a receptor for lipoproteins that carry lipids from the gut to the liver (Rohlmann et al. 1998).”
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis
Gordts, P. L. S. M., & Esko, J. D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.010 · Cited by 54
Obesity and post-prandial lipid metabolism. Feast or famine?
Martins, I. J., & Redgrave, T. G. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.10.006 · Cited by 60
Sugiyama, T., Kumagai, H., Morikawa, Y., Wada, Y., Sugiyama, A., Yasuda, K., Yokoi, N., Tamura, S., Kojima, T., Nosaka, T., et al. (2000) · Biochemistry · doi:10.1021/bi001583s · Cited by 51
Moon, J. H., Kang, S. B., Park, J. S., Lee, B. W., Kang, E. S., Ahn, C. W., Lee, H. C., & Cha, B. S. (2011) · Metabolism · doi:10.1016/j.metabol.2010.08.013 · Cited by 50
“Furthermore, LRP1 plays an important role in the clearance of remnant of triglyceride-rich lipoproteins such as chylomicron remnant or very lowdensity lipoprotein remnant [3,4].”
BackgroundXiong, L. H., Ren, F., Lv, J., Zhang, H., & Guo, H. (2018) · Food & Function · doi:10.1039/c8fo00317c · Cited by 58
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 52
Gatward, L. F. D., Kennard, M. R., Smith, L. I. F., & King, A. (2021) · Diabetic Medicine · doi:10.1111/dme.14711 · Cited by 64
Basford, J. E., Wancata, L., Hofmann, S. M., Silva, R. A. G. D., Davidson, W. S., Howles, P. N., & Hui, D. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229369 · Cited by 49
Yazdanyar, A., & Jiang, X. (2012) · Hepatology · doi:10.1002/hep.25648 · Cited by 50
“Plasma apoE, apoB, and apoA-I levels were determined as described.(26) Briefly, 0.”
The Adaptor Protein β-Arrestin2 Enhances Endocytosis of the Low Density Lipoprotein Receptor
Wu, J.-H., Peppel, K., Nelson, C. D., Lin, F.-T., Kohout, T. A., Miller, W. E., Exum, S. T., & Freedman, N. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309450200 · Cited by 49
Apolipoprotein B Metabolism: Tracer Kinetics, Models, and Metabolic Studies
Burnett, J. R., & Barrett, P. H. R. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360208951113 · Cited by 54
Qu, J., Fourman, S. M., Fitzgerald, M. E., Liu, M., Nair, S., Osés-Prieto, J. A., Burlingame, A. L., Morris, J. H., Davidson, W. S., Tso, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92711-0 · Cited by 51
Muratoglu, S. C., Belgrave, S., Lillis, A. P., Migliorini, M., Robinson, S., Smith, E., Zhang, L., & Strickland, D. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028846 · Cited by 48
“Herz, Dallas) as described [43] to generate LDLR,LRP1 mice.”
BackgroundLRP1: A chameleon receptor of lung inflammation and repair
Wujak, L. A., Schnieder, J., Schaefer, L., & Wygrecka, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.12.007 · Cited by 50
Metadata
- Authors
- Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Max Delbrück Center (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-01
- Volume
- 101
- Issue
- 3
- Pages
- 689-695
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508614
- OpenAlex
- W2067089828
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 18 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 8 · 2013: 17 · 2012: 19
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- LDL receptor-related protein, LRP, chylomicron remnants, cholesterol clearance, LDL receptor, conditional gene targeting, Cre-loxP recombination, liver, LDL receptor-deficient mice, lipoprotein metabolism
- MeSH terms
- Animals, Chylomicrons, Liver, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Immunologic, Receptors, LDL, Recombination, Genetic, Viral Proteins, Mice, Knockout, Integrases, Low Density Lipoprotein Receptor-Related Protein-1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.